CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,568,000 | +11.2% | 800,000 | +23.1% | 3.26% | +24.3% |
Q2 2023 | $21,203,000 | +0.4% | 650,000 | +8.3% | 2.62% | -38.3% |
Q1 2023 | $21,114,000 | +15.2% | 600,000 | +50.0% | 4.25% | +10.6% |
Q4 2022 | $18,328,000 | +8.1% | 400,000 | +14.3% | 3.85% | +16.8% |
Q3 2022 | $16,958,000 | -17.8% | 350,000 | -33.3% | 3.29% | -22.4% |
Q2 2022 | $20,627,000 | +19.2% | 525,000 | +11.7% | 4.24% | -5.8% |
Q1 2022 | $17,301,000 | +16.8% | 470,000 | +44.6% | 4.50% | +9.8% |
Q4 2021 | $14,814,000 | +27.5% | 325,000 | 0.0% | 4.10% | +22.8% |
Q3 2021 | $11,616,000 | -16.1% | 325,000 | -53.6% | 3.34% | -12.5% |
Q2 2021 | $13,853,000 | -14.9% | 700,000 | 0.0% | 3.81% | -18.0% |
Q1 2021 | $16,282,000 | +49.2% | 700,000 | +33.3% | 4.65% | +43.4% |
Q4 2020 | $10,910,000 | +152.0% | 525,000 | +162.5% | 3.24% | +145.1% |
Q3 2020 | $4,330,000 | -46.0% | 200,000 | -41.2% | 1.32% | -44.8% |
Q2 2020 | $8,014,000 | +112.4% | 340,000 | +6.2% | 2.40% | +44.4% |
Q1 2020 | $3,773,000 | – | 320,000 | – | 1.66% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |